Evidence map›Paper›PMID 37431840›Full record

ArticleDalton transactions (Cambridge, England : 2003)2023

Indolo[2,3-

Christopher Wittmann, Orsolya Dömötör, Irina Kuznetcova, Gabriella Spengler, Jóhannes Reynisson, Lauren Holder, Gavin J Miller, Eva A Enyedy, Ruoli Bai, Ernest Hamel and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Christopher WittmannInstitute of Inorganic Chemistry, University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria. vladimir.arion@univie.ac.at.
Orsolya DömötörMTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.ORCID http://orcid.org/0000-0001-8736-3215
Irina KuznetcovaInstitute of Inorganic Chemistry, University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria. vladimir.arion@univie.ac.at.ORCID http://orcid.org/0000-0002-7425-3700
Gabriella SpenglerMTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.
Jóhannes ReynissonSchools of Chemical and Physical Sciences and Pharmacy and Bioengineering, Keele University, Staffordshire, ST5 5BG, UK.ORCID http://orcid.org/0000-0003-4174-9512
Lauren HolderSchools of Chemical and Physical Sciences and Pharmacy and Bioengineering, Keele University, Staffordshire, ST5 5BG, UK.
Gavin J MillerSchools of Chemical and Physical Sciences and Pharmacy and Bioengineering, Keele University, Staffordshire, ST5 5BG, UK.ORCID http://orcid.org/0000-0001-6533-3306
Eva A EnyedyMTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.ORCID http://orcid.org/0000-0002-8058-8128
Ruoli BaiMolecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland 21702, USA.
Ernest HamelMolecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland 21702, USA.
Vladimir B ArionInstitute of Inorganic Chemistry, University of Vienna, Währinger Strasse 42, A-1090 Vienna, Austria. vladimir.arion@univie.ac.at.ORCID http://orcid.org/0000-0002-1895-6460
Keele University · GBUniversity of Szeged · HUUniversity of Vienna · ATNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of four indolo[2,3-

Indexed as

Antineoplastic AgentsCoordination ComplexesHeterocyclic CompoundsCopperCrystallography, X-RayLigandsMagnetic Resonance SpectroscopyMicrotubulesModels, MolecularTubulinAntineoplastic AgentsCoordination ComplexesCopperHeterocyclic CompoundsLigandsTubulin

Identifiers

PMID37431840
PMCPMC10368209
OpenAlexW4383110866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.